Management of unknown primary head and neck squamous cell carcinomas has evolved as the incidence of p16 positive disease among head and neck cancer patients has increased.

Recent studies have led to radical change in concepts when considering Radiation Therapy for indolent lymphomas. This activity reviews clinical and practical updates in regards to dose considerations, patient selection and radiation techniques for this heterogenous group of patients.

Recent studies have led to radical change in concepts when considering Radiation Therapy for indolent lymphomas. This activity reviews clinical and practical updates in regards to dose considerations, patient selection and radiation techniques for this heterogenous group of patients.

A practicing radiation oncologist increasingly requires knowledge of the business and economic aspects of medical practice.

A practicing radiation oncologist increasingly requires knowledge of the business and economic aspects of medical practice.

ASTRO CEO Vivek Kavadi, MD, MBA, FASTRO, conducts a strategic dialogue.
 

ASTRO CEO Vivek Kavadi, MD, MBA, FASTRO, conducts a strategic dialogue.
 

Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology.

Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology.

This activity is designed for radiation oncologists, focusing on managing bone metastases. One of the three presentations exclusively explores stereotactic body radiation therapy (SBRT) for non-spinal bone metastases. Supporting data guides discussions on SBRT's effectiveness and strategies.